Bioactive Compounds
-
B1525 SSR128129ESummary: allosteric inhibitor of FGFR1, orally-active -
B3249 VanoxerineSummary: potent and selective DRI (Dopamine reuptake inhibitor) -
B3255 MeisoindigoSummary: Apoptosis inducer;potential agent for AML -
B1163 MK-4827 hydrochlorideSummary: PARP1/PARP2 inhibitor -
C5850 SD 1692 CitationSummary: selective ATP competitive inhibitor of the MAP kinases p38α and p38β -
A1054 Angiotensin 1/2 (1-7) amideSummary: Vasoconstrictor -
B8480 BroxaldineSummary: An antiprotozoal drug -
B6197 PF-CBP1 hydrochlorideSummary: CBP/p300 bromodomain inhibitor -
B7836 DifopeinSummary: 14.3.3 Protein Inhibitor -
C3069 O-MethylviridicatinSummary: blocks activation of the HIV long terminal repeat by TNF-α

